Spiegel R. — Psychopharmacology: an introduction :: Электронная библиотека попечительского совета мехмата МГУ

Главная Ex Libris Книги Журналы Статьи Серии Каталог Wanted Загрузка ХудЛит Справка Поиск по индексам Поиск Форум

Авторизация

Поиск по указателям

Spiegel R. — Psychopharmacology: an introduction

Обсудите книгу на научном форуме

Нашли опечатку?
Выделите ее мышкой и нажмите Ctrl+Enter

Название: Psychopharmacology: an introduction

Автор: Spiegel R.

Аннотация:

Describes the latest advances in psychopharmacology - one of the most rapidly developing fields in modern science. This latest edition has been updated to cover new developments in drug therapy and research including newly introduced antipsychotics, antidepressants and antidementia drugs. Sections on the treatment of depression and dementia have been revised to include new developments in treatment strategies. It will be welcomed for its essentially clinical and psychological approach to modern pharmaceuticals, their therapeutic uses and limitations, adverse reactions and future directions for research.

Язык:

Рубрика: Медицина и здравоохранение/

Статус предметного указателя: Готов указатель с номерами страниц

ed2k: ed2k stats

Издание: fouth edition

Год издания: 2003

Количество страниц: 400

Добавлена в каталог: 11.12.2005

Операции: Положить на полку | Скопировать ссылку для форума | Скопировать ID

Предметный указатель

Gastrointestinal disorders      14 20 17
GCP      see good clinical practice
Geigy      41—42 48
Gene technology      140
Generalized anxiety disorder (GAD)      169 291—292 296
Genes      139
Genes, loci of      140
Genetic disorders      141
Genetic screening      141
Genetics      139
Genomic approach      140
Genotyping      140
Gerbils, laboratory tests and      134
Glia cells      101
Glucose derivatives, in functional imaging      208
Glutamate      110
Glycine      110 117
Glycosides      28
Good clinical practice (GCP), principles of      150
Granulocytopenia      51
Grapefruit juice      160 161
Griesinger, W.      34—36
Grimacing      8
Guinea pigs, injected with urine of manic patients      43
Habituation      162 261
HADS      see Hospital Anxiety and Depression Scale
Hair loss      17
Halazepam      19
Halcion $\textregistered$       19
Haldol $\textregistered$       5
Hallucinations      6
Hallucinations and LSD      112
Hallucinations in schizophrenia      41 113 228 232
Hallucinations, hypnagogic      25
Hallucinations, paranoid      4
Hallucinations, psychotic      24 151
Hallucinations, reduction of      34 256 263
Hallucinations, side effects of      114
Hallucinogenic drugs      323
Haloperidol      5 52 96
Haloperidol, cognitive impairment      78
Haloperidol, effects of      77—79 95
Haloperidol, pharmocodynamics of      6
Haloperidol, receptor blockade by      127
Haloperidol, specificity of      161
Haloperidol, studies/trials of      177—178 232—233 263 265—267 278
Hamilton Rating Scale for Anxiety (HRSA)      199—200
Hamilton Rating Scale for Depression (HRSD)      154 167 177 197 202—203 239 285
Hamilton Rating Scale for Depression (HRSD), multiple uses of      198
Hamilton Rating Scale for Depression (HRSD), subscales of      198
Hamon, J.      47
Hanoi test      70
Hashish      27—28 35
Hashish, uses of      28
Hay fever      38
Headaches      13—14 20—21 23 62 307
Health economics and psychopharmacology      301—317
Health economics and psychopharmacology, perspectives of economic analysis      304—305 308
Healthcare costs      303
Heart rate, increase in      124 129
Hellebore      27 29—30
Hellebore, black      28—29
Hellebore, mentioned by ancients      29
Hellebore, root of      28
Hellebore, white      28—29
Hemoglobin, in functional imaging      208
Hemp      28
Henbane      34
Henbane, uses of      30
Hepatic impairment      194
Heroin      1—2
Hexamethylpropyleneamine oxime (HMPAO)      209
Hexokinase activity, and FDG-PET      226
Hippocrates      148
Hippocratic oath      149
Histamine      37—38
Histamine, receptors      52
HIV      194
Hoffmann — La Roche      41 44—15 48
Hormonal shifts, caused by antipsychotics      7
Hospital Anxiety and Depression Scale (HADS)      200
HRSA      see Hamilton Rating Scale for Anxiety
HRSD      see Hamilton Rating Scale for Depression
Human and animal behavior, analogies and homologies of      129—130
Humoral theory of      30—31
Hydergine $\textregistered$       26
Hydrogen in MRI      211—212 226
Hydrophobia      29
Hyoscine      35—36
Hyoscvamus niger      34
Hypercortisolemia      142
Hyperfunctionality, disorders due to      126—127
Hypericum perforatum      177
Hypericum perforatum, effects of      81—82
Hyperlipidemia      258—259
Hypersensitivity      21
Hypersomnia      24
Hyperthermia      8
Hyperthermia, stress-induced      135—136
Hypervigilance      292
Hypnograms      71 74
Hypnotic drugs (hypnotics)      2—3 17—23 35—36 58 82—85
Hypnotic drugs (hypnotics) on healthy subjects      84
Hypnotic drugs (hypnotics), benzodiazepine      26
Hypnotic drugs (hypnotics), benzodiazepine, after-effects of      20
Hypnotic drugs (hypnotics), best known products      18 (19)
Hypnotic drugs (hypnotics), clinical actions and uses      17—18
Hypnotic drugs (hypnotics), discovery/introduction of      41
Hypnotic drugs (hypnotics), effects of      244
Hypnotic drugs (hypnotics), experiments on      82—85
Hypnotic drugs (hypnotics), experiments on, behavioral effects      83—85
Hypnotic drugs (hypnotics), experiments on, neurophysiology      85
Hypnotic drugs (hypnotics), experiments on, subjective effects      82—83
Hypnotic drugs (hypnotics), pharmacodynamics of      6
Hypnotic drugs (hypnotics), side effects of      7—8
Hypnotic drugs (hypnotics), side effects of, dependency and      261
Hypnotic drugs (hypnotics), studies/trials "of      59 179
Hypnotic drugs (hypnotics), withdrawal problems of      21
Hypofunctionality, disorders due to      125—126
Hypomania      1 15—16 173
Hypomimia      8
Hyponatremia      14
Hypotension, orthostatic      7—8 13—14
Hypothyroidism      17
Iatrogenesis      7
Ibuprofen      257
ICD      see International Classification of Diseases
ICD-10      197
IDS-SR      see Inventory of Depressive Symptomatology — Self Report
Igmesine, and depression      123
Illusions, psychotic      3—4
Iminodibenzyl      49
Imipramine      11 112
Imipramine and bipolar disorder      279
Imipramine and catecholamines      119
Imipramine and depression      120
Imipramine and noradrenaline      118
Imipramine and norepinephrine      52—53
Imipramine and QT interval      163
Imipramine and serotonin      119
Imipramine, action spectra of      12
Imipramine, discovery/introduction of      42—43 45—47 49
Imipramine, effects of      79 81 95 118—119 187
Imipramine, efficacy of      13 235—236 275
Imipramine, specificity of      126
Imipramine, studies/trials of      133 285—286 293
Impotence      8 13 267
Indifference      263
Inflammation      29
Informed consent      151

Inhibitors, multiple uptake      122
Injections      6
Insane, treatment of the      32
Insanity      29 31
Insidon $\textregistered$       11
Insomnia      3 6 14 19 21 25—26 58 232 239
Institutional review boards      151—152
Insulin shock      46
Interaction, social      131 136
International Classification of Diseases (ICD)      3
Interpersonal therapy      285
Interpersonal therapy and drug treatment      287—288
Interpersonal therapy, studies in depression      286—288
Inventory of Depressive Symptomatology — Self Report (IDS-SR)      199
Iodine $(^{123}I)$ halides, in functional imaging      209
Iprindol      12
Iproniazid      41 43
Irritability      25 292
Isocarboxazide      12 41
Itil, T.M.      76
James, W.      323
Janke, W.      96 323
Janssen Pharmaceuticals      52
Ketamine      131
Kety, S.      215
Kidney      17
Kielholz, P.      40
Klerman,G.L.      286
Klonopin $\textregistered$       19
Koetschet, P.      38
Kraepelin, E.      27 34—36 91 228 319
Kraepelin, E., pharmaceutical listed by      35
Kraepelin, E., studies conducted by      59—61
Kraepelin, E., studies conducted by, lack of statistical tests in      60
Krawiecka — Goldberg Scale      202
Kuhn, R.      41—42 48—49
L-DOPA      54 114 125—126
L-dopa and depression      120
Labhardt, F.      39—40
Laborit. H.      37—39 47
Lactation, caused by antipsychotics      7
Lamictal $\textregistered$       16
Lamor frequency      212
Lamotrigine      16 241 279
Lamotrigine, side effects of      17
Langley      221
Language skills and verbal functions      69
Largactil $\textregistered$       5 39—40
Latin square design      179
Laudanum      28
Laxative      28 30
LCM      see Life Charting Methodology
Learned helplessness test      132
Learning and memory      67—68
Learning and memory, processes of      67
Learning and memory, state-dependent      68
Learning and memory, time criticality of tests for      67—68
Lecithin      54
Lehrhttch der Psrchiatrie      35
Leipzig, University of      59
Leponex $\textregistered$       5
Levodopa      313—315
Levomepromazine      5 6 12
Lewy body disorder      253 256
Lexapro $\textregistered$       11
Lexotan $\textregistered$       19
Lezak, M.B.      65 227 229
Librmm $\textregistered$       45 19
Liebowitz Social Anxiety Scale (LSAS)      169 200
Lienert      323
Life Charting Methodology (LCM)      203
Life skills training      273
Ligands      108—109
Ligands, agonists      108
Ligands, antagonists      108
Ligands, interaction with receptors      109
Ligands, labelled      221—222
Light/dark box test      135
Limbritol $\textregistered$       19
Linkage studies      123
Linkage studies and depression      123
Lipophilicity      156 158
Lips, dyskinetic movements of      7
Lithium and affective disorder      193
Lithium and bipolar disorder      15—16
Lithium and suicide      183
Lithium in pregnancy      182—183
Lithium, in MRI      225—226
Lithium, antimanic effects of      27 43
Lithium, carbonate      47
Lithium, discovery/introduction of      43 45—47 49
Lithium, effects of      81—82 240—241
Lithium, problems with      240
Lithium, properties of      49
Lithium, side effects of      17
Lithium, studies/trials of      173 278—279 290
Lithium, toxicity of      43
Lithium, urate      47
Lithobid $\textregistered$       16
Lithonate $\textregistered$       16
Lorazepam      19 161
Lorazepam, effects of      242
Lorazepam, interaction with caffeine      87
Lorazepam, studies/trials of      84—85 183 189 243
Lorichms, R.      27
Lormetazepam      19
Loxapine      5
Loxitane $\textregistered$       5
LSAS      see Liebowitz Social Anxiety Scale
LSD      see lysergic acid diethylamide
Ludiomil $\textregistered$       11
Luvox $\textregistered$       11
Lyogen $\textregistered$       5
Lysergic acid diethylamide (LSD)      2 112—113 323
Lytic cocktails      38
Mackworth Clock      65
Madness      29 31
MADRS      see Montgomery — Asberg Depression Rating Scale
Magnetic resonance imaging (MRI)      123 211—214 225 254
Magnetic resonance imaging (MRI) and depression      123
Magnetic resonance imaging (MRI), blood-oxygen-level-dependent (BOLD)      213—214 218—219
Magnetic resonance imaging (MRI), functional (fMRI)      70 162 214—226 324 Plate
Magnetic resonance imaging (MRI), with Gd-DTPA      218
Magnetic resonance spectroscopy (MRS)      212
Magnetic resonance spectroscopy (MRS), assessing drug disposition with      225—226
Maintenance therapy, problems of      277—278
Malaria therapy      46
Manchester Scale      202
Manerix $\textregistered$       11
Mania      1 3 10 29
Mania and bipolar disorder      13 15—16 43 166
Mania, acute      19 278
Mania, dysphoric      15
Mania, scales for      202—203
Mania, studies of      39 47 169
Mania, symptoms of      15
Mania, treatment of      128 241 278—279
Manic depression      15 43 278
Manic depression, etiology of      43
Manic State Rating Scale      202
Mannerisms      263
MAO      see monoamine oxidase
Maprotiline      11 163 236 279
Maprotiline, action spectra of      12
Maprotiline, effects of      79
Marihuana      2 28 323
Markers, biological      162—164
Markov model      314—315
Maximum tolerated dose (MTD)      162
Medical model, the      34

1 2 3 4 5 6 7 8

О проекте